Bookmarks

Welsh Neuroscience Research Tissue Bank

Datasets(4)

DECISIve Biorepository (Cardiff)

Dataset population size: 25

Health and disease, Treatments/Interventions, Measurements/Tests, Imaging types, Imaging area of the body

Welsh Neuroscience Research Tissue Bank (WNRTB)

Dataset population size: 3,431

Health and disease

DELIVER-MS Biorepository

Dataset population size: 504

Treatments/Interventions, Health and disease

Octopus Clinical Trial Biorepository

Dataset population size: 323

Health and disease, Treatments/Interventions

Publications(20)

Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.Welsh Neuroscience Research Tissue Bank

Kodosaki E, Watkins WJ, Loveless S, Kreft KL, Richards A, Anderson V, Hurler L, Robertson NP, Zelek WM, Tallantyre EC.

Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.Welsh Neuroscience Research Tissue Bank

Kreft KL, Uzochukwu E, Loveless S, Willis M, Wynford-Thomas R, Harding KE, Holmans P, Lawton M, Tallantyre EC, Robertson NP.

CSF-resident CD4<sup>+</sup> T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis.Welsh Neuroscience Research Tissue Bank

Hrastelj J, Andrews R, Loveless S, Morgan J, Bishop SM, Bray NJ, Williams NM, Robertson NP.

Detecting and predicting neutralization of alemtuzumab responses in MS.Welsh Neuroscience Research Tissue Bank

Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS.

Detecting and predicting neutralization of alemtuzumab responses in MS.Welsh Neuroscience Research Tissue Bank

Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS.

Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.Welsh Neuroscience Research Tissue Bank

Zelek WM, Watkins LM, Howell OW, Evans R, Loveless S, Robertson NP, Beenes M, Willems L, Brandwijk R, Morgan BP.

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis.Welsh Neuroscience Research Tissue Bank

Welton JL, Loveless S, Stone T, von Ruhland C, Robertson NP, Clayton A.

Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.Welsh Neuroscience Research Tissue Bank

Hakobyan S, Luppe S, Evans DR, Harding K, Loveless S, Robertson NP, Morgan BP.

Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administration.Welsh Neuroscience Research Tissue Bank

Gelissen LMY, Loveless S, Toorop AA, Howlett J, Loeff FC, Rispens T, Killestein J, Tallantyre EC, van Kempen ZLE.

Complement system biomarkers in epilepsy.Welsh Neuroscience Research Tissue Bank

Kopczynska M, Zelek WM, Vespa S, Touchard S, Wardle M, Loveless S, Thomas RH, Hamandi K, Morgan BP.

A high-density 3-dimensional culture model of human glioblastoma for rapid screening of therapeutic resistance.Welsh Neuroscience Research Tissue Bank

Brown JMC, Zaben M, Ormonde C, Sharouf F, Spencer R, Bhatt H, Siebzehnrubl FA, Gray WP.

IL-1β and HMGB1 are anti-neurogenic to endogenous neural stem cells in the sclerotic epileptic human hippocampus.Welsh Neuroscience Research Tissue Bank

Zaben M, Haan N, Sharouf F, Ahmed A, Sundstrom LE, Gray WP.

Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years.Welsh Neuroscience Research Tissue Bank

Muller I, Willis M, Healy S, Nasser T, Loveless S, Butterworth S, Zhang L, Draman MS, Taylor PN, Robertson N, Dayan CM, Ludgate ME.

Seroprevalence of Molluscum contagiosum virus in German and UK populations.Welsh Neuroscience Research Tissue Bank

Sherwani S, Farleigh L, Agarwal N, Loveless S, Robertson N, Hadaschik E, Schnitzler P, Bugert JJ.

Systemic complement profiling in multiple sclerosis as a biomarker of disease state.Welsh Neuroscience Research Tissue Bank

Ingram G, Hakobyan S, Hirst CL, Harris CL, Loveless S, Mitchell JP, Pickersgill TP, Robertson NP, Morgan BP.

Complement regulator factor H in multiple sclerosis.Welsh Neuroscience Research Tissue Bank

Ingram G, Hakobyan S, Loveless S, Robertson N, Morgan BP.

Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity.Welsh Neuroscience Research Tissue Bank

Ingram G, Bugert JJ, Loveless S, Robertson NP.

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.Welsh Neuroscience Research Tissue Bank

Ingram G, Hakobyan S, Hirst CL, Harris CL, Pickersgill TP, Cossburn MD, Loveless S, Robertson NP, Morgan BP.

CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.Welsh Neuroscience Research Tissue Bank

Naughton M, Moffat J, Eleftheriadis G, de la Vega Gallardo N, Young A, Falconer J, Hawkins K, Pearson B, Perbal B, Hogan A, Moynagh P, Loveless S, Robertson NP, Gran B, Kee R, Hughes S, McDonnell G, Howell O, Fitzgerald DC.

Cerebrospinal fluid complement system biomarkers in demyelinating disease.Welsh Neuroscience Research Tissue Bank

Zelek WM, Fathalla D, Morgan A, Touchard S, Loveless S, Tallantyre E, Robertson NP, Morgan BP.

Associated collections(1)

Research Study Cohorts on the Gateway

Welsh Neuroscience Research Tissue Bank

Datasets

Collections

Analysis Scripts & Software

Data Uses

Publications